Blog

SNP Genotyping Assays: Design, Technology, and Applications

SNP Genotyping Assays: Design, Technology, and Applications

As access to and the the possibilities for demand for precise and scalable genetic analysis grows globally, SNP genotyping has emerged as one of the most widely adopted tools in both research and applied biosciences.Whether you’re investigating disease resistance or quality traits in crops, uncovering associations with human disease, or conducting large-scale population genetics studies, reliable genotyping assays are essential.

In this blog, we’ll explore the fundamentals and intricacies of SNP genotyping with allele-specific PCR assays, dig into the importance of strategic PCR assay design, and look at the evolving technology behind allele-specific PCR for high-throughput SNP Genotyping. Along the way, we’ll showcase how 3CR Bioscience’s PACE Genotyping Assays and PACE Genotyping Master Mixes system are technology leaders for allele-specific SNP genotyping, offering unmatched flexibility, precision, and cost efficiency.

What Is SNP Genotyping?

Single Nucleotide Polymorphisms (SNPs) are single-base changes in the DNA sequence, and they occur frequently throughout the genome. These variations make SNPs ideal molecular markers for identifying genetic differences between individuals or populations. Due to their abundance and distribution, SNPs are used in a wide range of genetic studies, including:

  • Genetic diversity analysis
  • Linkage mapping
  • Quantitative trait loci (QTL) identification
  • Genome-Wide Association Studies (GWAS)
  • Marker-Assisted Selection (MAS)
  • Genomic selection in breeding programs

Additionally, insertions and deletions (Indels) are another valuable type of genetic variation, involving the addition or removal of small sequences of DNA. Indels are particularly useful in population genetics, trait mapping, and disease association studies.

Both SNPs and Indels can be genotyped using allele-specific PCR techniques, and assay design and chemistry play a crucial role in ensuring reliable detection, particularly in high-throughput applications.

Why Assay Design Matters

A genotyping assay is only as effective as its design. Poorly designed assays can lead to off-target amplification, allele dropout, or inconsistent results. A successful SNP genotyping assay depends on multiple factors, including the target sequence, flanking regions, polymorphism context, and detection chemistry.

Here are several critical considerations when designing your PCR-based genotyping assays:

1. High-Quality Sequence Information

The accuracy of genotyping starts with the quality of the sequence data. Ideally, at least 50 nucleotides upstream and downstream of the target SNP are needed for optimal primer design. This ensures that primers can be positioned correctly for selective and specific binding. While some assays can function with fewer bases, more sequence context improves performance and reduces the risk of primer-dimer formation or mispriming.

2. Avoiding Nearby Polymorphisms

Unidentified SNPs or Indels near your target site can interfere with primer binding and reduce assay specificity. By understanding and mapping nearby variants, you can refine your assay design to avoid regions prone to genetic variation, increasing both accuracy and reproducibility.

3. Dealing with Homology

In cases where similar sequences exist elsewhere in the genome, non-specific amplification can occur. If genomic homology is suspected, incorporating unique anchor bases near the SNP of interest can enhance selectivity. These bases ensure that only the desired region is amplified, boosting signal clarity.

PACE®: A Technology-Leading Allele-Specific PCR System

Developed by 3CR Bioscience, PACE (PCR Allele Competitive Extension) is a cutting-edge allele-specific PCR chemistry optimised for SNP and Indel detection. PACE builds on traditional PCR principles but incorporates advanced features for increased performance, cost-efficiency, and adaptability.

Diagram showing allele-specific PCR using PACE®, with two forward primers, one reverse primer, and fluorescence detection of SNP genotypes.

The PACE Reaction Explained

PACE reactions utilize:

  • Two allele-specific forward primers, differing only at their 3′ ends.
  • A common reverse primer, located downstream of the SNP or Indel.
  • Universal fluorescent reporting cassettes, contained in the master mix.

Visual of multiplexed SNP genotyping assay using PACE® chemistry, detecting multiple genetic targets in a single PCR reaction.

During amplification:

  • If the SNP is homozygous, only one allele-specific primer binds and one fluorescent signal is emitted.
  • If the SNP is heterozygous, both allele-specific primers bind, and both fluorophores are activated, producing a mixed signal.

This fluorescence is detected either via endpoint analysis (e.g., plate reader) or real-time PCR (qPCR machine). PACE’s reporting mechanism ensures that results are both accurate and machine-readable across a range of platforms.

Genotyping result showing fluorescence cluster plot from a PACE® SNP assay, indicating homozygous and heterozygous allele calls.

Check out our video of the PACE mechanism for more detailed explanation.

Types of Variants PACE Can Detect

PACE Genotyping Assays offer remarkable flexibility, supporting a wide variety of genetic variants, including:

  1. Biallelic SNPs – the most common SNP format.
  2. Single-base Indels – small insertions or deletions at the base-pair level.
  3. Small Indels – up to several bases in length.
  4. Large Indels with known junctions – where primer placement is predictable.
  5. Large Indels without known junctions – requiring customized primer strategies.

In addition, PACE Multiplex Master Mix allows for up to four targets in a single reaction:

  • Two SNPs in one tube
  • Tri- and tetra-allelic SNPs
  • Three genes + a reference gene in one assay

This level of multiplexing reduces costs, saves time, and increases throughput, making it ideal for high-volume labs and breeding programs.

Technology Compatibility and Versatility

PACE reactions are compatible with all major genotyping platforms and thermal cyclers, including:

  • 96-well, 384-well, and 1536-well PCR plates
  • Array Tape® systems
  • qPCR machines and fluorescent plate readers

Furthermore, PACE reagents are fully compatible with KASP™ and Amplifluor™ markers, which also use the same 5′ tail sequence design. This means researchers can transition to PACE without redesigning existing assays — maximizing both backward compatibility and future scalability.

Beyond SNP Genotyping: Emerging Applications

PACE chemistry is not limited to SNP and Indel detection. Its versatility opens the door to several other applications:

  • Pathogen detection– enabling rapid identification of viruses, bacteria, or fungi via sequence-specific amplification.
  • Transgenic sequence detection – confirming the presence of engineered genes in GMOs or experimental lines.
  • One-Step RT-PCR – with the PACE OneStep RT-PCR Master Mix, researchers can genotype directly from RNA, ideal for expression studies or viral RNA detection.

PACE supports both endpoint and real-time detection, making it a go-to solution for a wide range of molecular biology applications.

The Evolution of Allele-Specific PCR

Since its first description by Newton et al. in 1989, allele-specific PCR (AS-PCR) has evolved from a niche genotyping method into a robust and widely used platform. Modern genotyping chemistries — like PACE — retain the core competitive primer strategy but improve on it with better fluorescent detection, universal reagents, and increased assay robustness.

The latest systems, including those offered by 3CR Bioscience, focus on:

  • Improved performance with crude DNA or low-template samples
  • Increased multiplexing capabilities
  • Direct genotyping from RNA
  • Universal cassettes for fluorescence detection

These innovations reduce per-sample costs and simplify assay setup, making high-throughput genotyping more accessible than ever.

Why Choose 3CR Bioscience?

At 3CR Bioscience, we combine technical excellence with a strong commitment to customer support. Our scientists work hand-in-hand with researchers to design, optimize, and scale genotyping assays for projects of all sizes — from small academic studies to enterprise-scale breeding programs.

We offer:

  • Free assay design for all PACE Master Mix customers
  • Custom assay design services
  • Tailored genotyping solutions
  • Flexible reagent volumes
  • Rapid turnaround and technical support

If you’re exploring SNP genotyping for the first time or scaling up an existing workflow, we’re here to help you succeed.

Let’s Work Together

Interested in learning more about how PACE can enhance your genotyping workflow?
Looking for expert input on PCR assay design?

Contact us at support@3crbio.com — our team is ready to assist with assay development, troubleshooting, and custom project planning.

You can also read our technotes on the subject:

Top 5 Assay Designs for SNP and Indel Genotyping

Genotyping Data: A Practical Guide for Optimisation

In Summary

SNP genotyping assays have transformed how researchers understand and manipulate genetic variation. With the right combination of thoughtful assay design, proven allele-specific PCR chemistry, and flexible, cost-effective reagents, projects of any scale can be tackled with confidence.

PACE®, developed by 3CR Bioscience, represents the next generation of genotyping technology — combining precision, adaptability, and affordability into one powerful platform.

Partner with us and accelerate your genotyping workflow.

Automated PCR system for SNP genotyping assays using high-density microplates and robotic precision, ideal for large-scale allele-specific detection with PACE®.

MORE POSTS

Automated PCR system for SNP genotyping assays using high-density microplates and robotic precision, ideal for large-scale allele-specific detection with PACE®.
SNP Genotyping Assays: Design, Technology, and Applications
PACE for rapid, sensitive pathogen detection - customised precision technology for the fast, one-step detection of DNA and RNA-based pathogens. Proven efficacy and sensitivity across agricultural, veterinary, and medical applications.
How Advanced Rapid Pathogen Detection Systems Are Transforming Healthcare 
PACE for rapid, sensitive pathogen detection - customised precision technology for the fast, one-step detection of DNA and RNA-based pathogens. Proven efficacy and sensitivity across agricultural, veterinary, and medical applications.
What is a PCR Master Mix? Components and Functions.
A general introduction to PCR master mixes followed by information on 3CR Bioscience’s PACE PCR Master Mixes, which provide cost-effective solutions for accurate SNP and Indel genotyping, using patented fluorescent technology for high-throughput, reliable allele-specific PCR analysis.
[fibosearch]
Name(Required)
This field is for validation purposes and should be left unchanged.

Contact us

MEET OUR TEAM

Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.